Substitute Senate Bill No. 945
Public Act No. 05-73
AN ACT CONCERNING THE PRACTICE OF PHARMACY.
Be it enacted by the Senate and House of Representatives in General Assembly convened:
Section 1. Section 20-581 of the general statutes is repealed and the following is substituted in lieu thereof (Effective from passage):
Any person who violates any provision of sections 20-570 to [20-630] 20-631, inclusive, and section 20-635 for the violation of which no other penalty has been provided shall be fined not more than five thousand dollars or imprisoned not more than five years or both. For purposes of this section, each instance of patient contact or consultation that is in violation of any provision of sections 20-570 to [20-630] 20-631, inclusive, and section 20-635 shall be a separate offense. Failure to renew in a timely manner any license issued under said sections is not a violation for purposes of this section.
Sec. 2. Section 21a-249 of the general statutes is amended by adding subsection (m) as follows (Effective from passage):
(NEW) (m) A practitioner authorized to prescribe controlled substances shall not prescribe anabolic steroids for the sole purpose of enhancing a patient's athletic ability or performance.
Sec. 3. (NEW) (Effective from passage) In the absence of a documented patient evaluation that includes a physical examination, any request for a controlled substance issued solely on the results of answers to an electronic questionnaire shall be considered to be issued outside the context of a valid practitioner-patient relationship and not be a valid prescription. The Commissioner of Consumer Protection may adopt regulations, in accordance with chapter 54 of the general statutes, concerning such requests for controlled substances. For the purposes of this section, "electronic questionnaire" means any form in an electronic format that may require personal, financial or medical information from a consumer or patient.
Approved May 31, 2005